MicroRNA and Posttranscriptional Dysregulation in Psychiatry
- PMID: 25636176
- DOI: 10.1016/j.biopsych.2014.12.009
MicroRNA and Posttranscriptional Dysregulation in Psychiatry
Abstract
Psychiatric syndromes, including schizophrenia, mood disorders, and autism spectrum disorders, are characterized by a complex range of symptoms, including psychosis, depression, mania, and cognitive deficits. Although the mechanisms driving pathophysiology are complex and remain largely unknown, advances in the understanding of gene association and gene networks are providing significant clues to their etiology. In recent years, small noncoding RNA molecules known as microRNA (miRNA) have emerged as potential players in the pathophysiology of mental illness. These small RNAs regulate hundreds of target transcripts by modifying their stability and translation on a broad scale, influencing entire gene networks in the process. There is evidence to suggest that numerous miRNAs are dysregulated in postmortem neuropathology of neuropsychiatric disorders, and there is strong genetic support for association of miRNA genes and their targets with these conditions. This review presents the accumulated evidence linking miRNA dysregulation and dysfunction with schizophrenia, bipolar disorder, major depressive disorder, and autism spectrum disorders and the potential of miRNAs as biomarkers or therapeutics for these disorders. We further assess the functional roles of some outstanding miRNAs associated with these conditions and how they may be influencing the development of psychiatric symptoms.
Keywords: Autism; Bipolar Disorder; Depression; Psychiatry; Schizophrenia; miRNA.
Copyright © 2015 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Postmortem human brain genomics in neuropsychiatric disorders--how far can we go?Curr Opin Neurobiol. 2016 Feb;36:107-11. doi: 10.1016/j.conb.2015.11.002. Epub 2015 Dec 10. Curr Opin Neurobiol. 2016. PMID: 26685806 Free PMC article. Review.
-
MicroRNAs as biomarkers for psychiatric disorders with a focus on autism spectrum disorder: Current progress in genetic association studies, expression profiling, and translational research.Autism Res. 2017 Jul;10(7):1184-1203. doi: 10.1002/aur.1789. Epub 2017 Apr 17. Autism Res. 2017. PMID: 28419777 Review.
-
miRNA regulation of social and anxiety-related behaviour.Cell Mol Life Sci. 2020 Nov;77(21):4347-4364. doi: 10.1007/s00018-020-03542-7. Epub 2020 May 14. Cell Mol Life Sci. 2020. PMID: 32409861 Free PMC article. Review.
-
Integration of multi-omics summary data reveals the role of N6-methyladenosine in neuropsychiatric disorders.Mol Psychiatry. 2024 Oct;29(10):3141-3150. doi: 10.1038/s41380-024-02574-w. Epub 2024 Apr 29. Mol Psychiatry. 2024. PMID: 38684796
-
The Dysregulation of microRNAs and the Role of Stress in the Pathogenesis of Mental Disorders.Curr Top Med Chem. 2018;18(21):1893-1907. doi: 10.2174/1568026619666181130135253. Curr Top Med Chem. 2018. PMID: 30499408 Review.
Cited by
-
The Role of microRNA in Schizophrenia: A Scoping Review.Int J Mol Sci. 2024 Jul 12;25(14):7673. doi: 10.3390/ijms25147673. Int J Mol Sci. 2024. PMID: 39062916 Free PMC article. Review.
-
Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional Intervention.Nutrients. 2024 May 21;16(11):1547. doi: 10.3390/nu16111547. Nutrients. 2024. PMID: 38892481 Free PMC article.
-
microRNA and the Post-Transcriptional Response to Oxidative Stress during Neuronal Differentiation: Implications for Neurodevelopmental and Psychiatric Disorders.Life (Basel). 2024 Apr 26;14(5):562. doi: 10.3390/life14050562. Life (Basel). 2024. PMID: 38792584 Free PMC article.
-
Can miRNA Expression Levels Predict Treatment Resistance to Serotonin Reuptake Inhibitors in Patients with Obsessive-Compulsive Disorder?Psychiatry Clin Psychopharmacol. 2022 Jun 1;32(2):98-106. doi: 10.5152/pcp.2022.22391. eCollection 2022 Jun. Psychiatry Clin Psychopharmacol. 2022. PMID: 38764867 Free PMC article.
-
Comparison of MicroRNA Levels of 18-60-month-old Autistic Children with Those of Their Siblings and Controls.Clin Psychopharmacol Neurosci. 2024 May 31;22(2):322-332. doi: 10.9758/cpn.23.1124. Epub 2024 Mar 22. Clin Psychopharmacol Neurosci. 2024. PMID: 38627079 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical